TRADE NEWS: Agilent Technologies Inc. Licenses KREATECH Biotechnology B.V. Technology, Enabling First CGH Microarrays Optimized for FFPE Samples

SANTA CLARA, Calif., & AMSTERDAM, The Netherlands--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE:A) and Kreatech Biotechnology B.V. announced today that Agilent has licensed novel labeling technology from Kreatech, which will optimize Agilent’s array-based comparative genomic hybridization (aCGH) platform for DNA from formalin-fixed paraffin-embedded (FFPE) tissue samples.

MORE ON THIS TOPIC